Progressive multifocal leukoencephalopathy in HIV-2 infection. Case report

Journal of Clinical Virology

Volumn 48, Issue 3, 2010, Pages 215-217

  Duque, Vítor ^a   Matos, Ana M ^b   da Cunha, J Saraiva ^a   Melico Sivestre A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

European; Female; HIV 2; Progressive multifocal leukoencephalopathy; White

Indexed keywords

DIDANOSINE; FLUCONAZOLE; INDINAVIR; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CAUCASIAN; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; DRUG ABUSE; ESOPHAGUS CANDIDIASIS; FEMALE; HEMIPARESIS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HYSTERECTOMY; LUMBAR PUNCTURE; MONONUCLEAR CELL; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; PORTUGAL; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN CONTENT; SEXUAL BEHAVIOR; UNSAFE SEX; UTERINE CERVIX CANCER; VIRUS LOAD;

BRAIN; CD4 LYMPHOCYTE COUNT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATAL OUTCOME; FEMALE; HIV INFECTIONS; HIV-2; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PORTUGAL;

EID: 77953127564     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.04.006     Document Type: Article

References (15)

1. Rubsamen-Waigman H., Adamski M., and Von Briesen H. Lethal progressive multifocal leukoencephalopathy in an HIV 2 infected person as the only AIDS manifestation. AIDS Forschung 2 (1987) 572-575
2. Stoner G.L., Agostini H.T., Ryschkewitsch C.F., et al. Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient. J Med Microbiol 47 8 (1998) 733-742
3. Bienaime A., Colson P., Moreau J., Zandotti C., Pellissier J.F., and Brouqui P. Progressive multifocal leukoencephalopathy in HIV-2-infected patient. AIDS 20 9 (2006) 1342-1343
4. Chan P.A., Wakeman S.E., Flanigan T., Cu-Uvin S., Kojic E., and Kantor R. HIV-2 diagnosis and quantification in high-risk patients. AIDS Res Ther 5 (2008) 18
5. Smallman-Raynor M., and Cliff A. The spread of human immunodeficiency virus type 2 into Europe: a geographical analysis. Int J Epidemiol 20 2 (1991) 480-489
6. INSA-Centro de Vigilância Epidemiológica das Doenças Transmissíveis. A situação em Portugal a 30 de Junho de 2003. SIDA Informação 130 (2003) 2
7. Gomes P., Abecasis A., Almeida M., Camacho R., and Mansinho K. Transmission of HIV-2. Lancet Infect Dis 3 11 (2003) 683-684
8. Mota-Miranda A., Gomes H., Serrão R., and Araújo F. Transmission of HIV-2: another perspective. Lancet Infect Dis 4 5 (2004) 265-266
9. Smith R.A., Gottlieb G.S., Anderson D.J., Pyrak C.L., and Preston B.D. Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro. Antimicrob Agents Chemother 52 1 (2008) 329-332
10. Fong I.W., and Toma E. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group. Clin Infect Dis 20 5 (1995) 1305-1310
11. Menéndez-Arias L., and Tözsér J. HIV-1 protease inhibitors: effects on HIV-2 replication and resistance. Trends Pharmacol Sci 29 1 (2008) 42-49
12. Matheron S., Pueyo S., Damond F., et al. Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS 17 18 (2003) 2593-2601
13. Zunt J.R., Tu R.K., Anderson D.M., Copass M.C., and Marra C.M. Progressive multifocal leukoencephalopathy presenting as human immunodeficiency virus type 1 (HIV)-associated dementia. Neurology 49 1 (1997) 263-265
14. Miralles P., Berenguer J., García de Viedma D., et al. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12 18 (1998) 2467-2472
15. Antinori A., Ammassari A., Giancola M.L., Cingolani A., Grisetti S., Murri R., et al. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J Neurovirol 7 (2001) 323-328